share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 12 21:56
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/12/2024, with an aggregate market value of $1,089,840. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on two separate dates, 02/10/2024 and 02/17/2024, totaling 864 and 1,416 shares respectively. This planned transaction follows a previous sale of the same number of shares on 05/29/2024, which grossed $1,015,876.80. The notice of the upcoming sale was filed on the same day as the planned sale date, with the instruction for the sale given earlier on 02/27/2024.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 06/12/2024, with an aggregate market value of $1,089,840. The shares to be sold were acquired through restricted stock vesting as part of compensation from the issuer on two separate dates, 02/10/2024 and 02/17/2024, totaling 864 and 1,416 shares respectively. This planned transaction follows a previous sale of the same number of shares on 05/29/2024, which grossed $1,015,876.80. The notice of the upcoming sale was filed on the same day as the planned sale date, with the instruction for the sale given earlier on 02/27/2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.